Stanford Training Program in Lung Biology

斯坦福大学肺生物学培训计划

基本信息

  • 批准号:
    9979930
  • 负责人:
  • 金额:
    $ 19.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-07-01 至 2021-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The demographics of physician-scientists have been skewed dramatically over the past decade, with the proportion of NIH-funded principal investigators in their 60s and 70s soaring and younger physician- scientists in marked decline. This shift is particularly noted in procedural disciplines, like pulmonary and critical care medicine, where lucrative clinical practices lure away talented doctors, who in another era would have entered academic medicine. At Stanford University, we seek to reverse this trend by inspiring individuals to enter discovery-based careers through exposure to a new and dynamic vision of science energized by brilliant new technologies emerging here and neighboring Silicon Valley. This new Stanford T32 Training Grant Proposal combines adult and pediatric pulmonary programs in order to select the most promising Trainees and provide an optimally diverse interdisciplinary training experience. Dr. Mark Nicolls, the adult chief and Dr. David Cornfield, the pediatric chief, will share Program Director responsibilities; each bringing unique and complementary skills to the leadership position. We have carefully screened 30 Mentors from the Stanford biomedical community with a strong track record of training and academic productivity. Based on the expertise of our Mentors, we have identified eight domains of excellence from which trainees can choose a primary focus for an individualized development plan. These research areas include: 1) Vascular Disease, 2) Stem Cells & Lung Development, 3) Genetics & Genomics, 4) Lung Injury & Repair, 5) Lung Microbiome, 6) Lung Cancer and 7) Outcomes Research, and 8) Imaging. The grant proposal outlines a process by which pulmonary/critical care fellows at Stanford are exposed to research areas, introduced to Mentors, and move through a selective process designed to identify Trainees with the best chance of success in academic medicine. We describe a well-supported and carefully constructed system of oversight to promote recruitment of underrepresented minorities. All T32 trainees will have an individualized development plan that includes a core curriculum and electives appropriate to their research domain. Through a longitudinal bimonthly T32 meeting lead by the PDs and quarterly informal meetings with T32 trainees, Mentors and PDs, Trainees will be immersed in a micro-culture of academic pulmonary medicine. A Scientific Oversight Committee will identify appropriate coursework and ensure ongoing and timely Trainee progress. We have assembled an experienced Internal Advisory Committee at Stanford and an acclaimed group, with strong Stanford ties, for the External Advisory Committee. We will utilize regular feedback from these groups, the Mentors and Trainees to identify programmatic strengths and weaknesses and reassess our processes to adjust, adapt and improve the T32 fellowship. While acknowledging the inherent challenges of retaining physicians in academic medicine, Stanford is particularly well poised to capture, develop and inspire the next generation of physician-scientists and clinical researchers.
 描述(由申请人提供):在过去的十年中,医生科学家的人口统计数据严重倾斜,NIH资助的60多岁和70多岁的主要研究者的比例飙升,年轻的医生科学家显着下降。这种转变在程序性学科中尤其明显,如肺部和重症监护医学,利润丰厚的临床实践吸引了有才华的医生,他们在另一个时代会进入学术医学。在斯坦福大学,我们寻求扭转这一趋势,鼓励个人进入发现为基础的职业生涯,通过接触到一个新的和动态的科学愿景,由辉煌的新技术在这里和邻近的硅谷新兴。这个新的斯坦福大学T32培训资助计划结合了成人和儿科肺部项目,以选择最有前途的学员,并提供最佳的多元化跨学科培训体验。马克尼科尔斯博士,成人主任和大卫康菲尔德博士,儿科主任,将分享项目主任的责任,每个人都带来了独特的和互补的技能,领导地位。我们从斯坦福大学生物医学界仔细筛选了30位导师,他们在培训和学术生产力方面有着良好的记录。根据导师的专业知识,我们确定了八个卓越领域,学员可以从中选择一个个性化发展计划的主要重点。这些研究领域包括:1)血管疾病,2)干细胞和肺发育,3)遗传学和基因组学,4)肺损伤和修复,5)肺微生物组,6)肺癌和7)结果研究,以及8)成像。拨款提案概述了一个过程,通过这个过程,斯坦福大学的肺部/重症监护研究员接触到研究领域,介绍给导师,并通过一个选择性的过程,旨在确定学员在学术医学上取得成功的最佳机会。我们描述了一个得到良好支持和精心构建的监督系统,以促进招聘代表性不足的少数民族。所有T32学员都将有一个个性化的发展计划,其中包括核心课程和适合其研究领域的选修课。通过由PD领导的纵向双月T32会议和与T32学员,导师和PD的季度非正式会议,学员将沉浸在学术肺医学的微观文化中。一个科学监督委员会将确定适当的课程,并确保持续和及时的培训生进展。我们在斯坦福大学组建了一个经验丰富的内部咨询委员会,并为外部咨询委员会组建了一个与斯坦福大学关系密切的知名团体。我们将利用这些团体,导师和学员的定期反馈,以确定方案的优势和弱点,并重新评估我们的流程,以调整,适应和改进T32奖学金。在承认留住学术医学医生的固有挑战的同时,斯坦福大学特别准备好捕捉,发展和激励下一代的医生科学家和临床研究人员。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID N. CORNFIELD其他文献

DAVID N. CORNFIELD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID N. CORNFIELD', 18)}}的其他基金

Stanford Training Program in Lung Biology
斯坦福大学肺生物学培训计划
  • 批准号:
    10652968
  • 财政年份:
    2016
  • 资助金额:
    $ 19.07万
  • 项目类别:
Stanford Training Program in Lung Biology
斯坦福大学肺生物学培训计划
  • 批准号:
    10089188
  • 财政年份:
    2016
  • 资助金额:
    $ 19.07万
  • 项目类别:
Stanford Training Program in Lung Biology
斯坦福大学肺生物学培训计划
  • 批准号:
    10379231
  • 财政年份:
    2016
  • 资助金额:
    $ 19.07万
  • 项目类别:
Postnatal Lung Development: Mechanisms of Molecular and Vascular Development
产后肺发育:分子和血管发育机制
  • 批准号:
    7936134
  • 财政年份:
    2009
  • 资助金额:
    $ 19.07万
  • 项目类别:
Postnatal Lung Development: Mechanisms of Molecular and Vascular Development
产后肺发育:分子和血管发育机制
  • 批准号:
    7861290
  • 财政年份:
    2009
  • 资助金额:
    $ 19.07万
  • 项目类别:
Molecular regulation of pulmonary vascular KCa Channels
肺血管 KCa 通道的分子调控
  • 批准号:
    6940632
  • 财政年份:
    2003
  • 资助金额:
    $ 19.07万
  • 项目类别:
Molecular Regulation of Pulmonary Vascular KCa Channel
肺血管 KCa 通道的分子调控
  • 批准号:
    8656382
  • 财政年份:
    2003
  • 资助金额:
    $ 19.07万
  • 项目类别:
Molecular regulation of pulmonary vascular KCa Channels
肺血管 KCa 通道的分子调控
  • 批准号:
    6773818
  • 财政年份:
    2003
  • 资助金额:
    $ 19.07万
  • 项目类别:
Molecular Regulation of Pulmonary Vascular KCa Channel
肺血管 KCa 通道的分子调控
  • 批准号:
    8490606
  • 财政年份:
    2003
  • 资助金额:
    $ 19.07万
  • 项目类别:
Molecular Regulation of Pulmonary Vascular KCa Channel
肺血管 KCa 通道的分子调控
  • 批准号:
    8288668
  • 财政年份:
    2003
  • 资助金额:
    $ 19.07万
  • 项目类别:

相似国自然基金

胚胎脑发育的分子机理:lgl2(late gestation lung 2)蛋白质的生物学功能的研究
  • 批准号:
    30470854
  • 批准年份:
    2004
  • 资助金额:
    18.0 万元
  • 项目类别:
    面上项目

相似海外基金

Interplay of the extracellular matrix and immune cells in lung pathology: key role for chitinase-like proteins
肺病理学中细胞外基质和免疫细胞的相互作用:几丁质酶样蛋白的关键作用
  • 批准号:
    MR/Y003683/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.07万
  • 项目类别:
    Research Grant
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
  • 批准号:
    10481965
  • 财政年份:
    2024
  • 资助金额:
    $ 19.07万
  • 项目类别:
Uncovering the epigenetic face of lung fibrosis for discovery of novel biomarkers and treatments.
揭示肺纤维化的表观遗传面,以发现新的生物标志物和治疗方法。
  • 批准号:
    MR/X032914/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.07万
  • 项目类别:
    Fellowship
Persistent micro- and nanoplastics as triggers for interstitial lung disease
持久性微塑料和纳米塑料是间质性肺病的诱因
  • 批准号:
    MR/Y012682/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.07万
  • 项目类别:
    Research Grant
気道上皮バリアに着目した肺NTM症Lung-on-a-chipモデルの構築と応用
关注气道上皮屏障的肺NTM疾病芯片肺模型的构建与应用
  • 批准号:
    24K19096
  • 财政年份:
    2024
  • 资助金额:
    $ 19.07万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 19.07万
  • 项目类别:
Interaction between immunity and airway remodelling in lung disease.
肺部疾病中免疫与气道重塑之间的相互作用。
  • 批准号:
    502582
  • 财政年份:
    2024
  • 资助金额:
    $ 19.07万
  • 项目类别:
Bioactive fragments of the extracellular matrix orchestrate lung epithelial cell repair.
细胞外基质的生物活性片段协调肺上皮细胞修复。
  • 批准号:
    BB/Y004183/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.07万
  • 项目类别:
    Research Grant
Tractable human distal lung organoid model as a new efficient tool to study mesenchymal-epithelial interactions in COPD
易处理的人远端肺类器官模型作为研究慢性阻塞性肺病间充质-上皮相互作用的新有效工具
  • 批准号:
    NC/Y500641/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.07万
  • 项目类别:
    Training Grant
Cellular dynamics in chronic lung disease: the neglected B cell axis
慢性肺病的细胞动力学:被忽视的 B 细胞轴
  • 批准号:
    MR/X03383X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.07万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了